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Folates and Pterins: Volume 3, 
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John Wiley; New York, 1986 
xiv + 482 pages. f94.45 
This is the last volume of a three-volume work 
which aims to act as a concise and up-to-date 
source of information on the chemistry and 
biochemistry of folates and pterins (volumes 1 and 
2), and to discuss clinical and physiological aspects 
of these compounds (in the present volume). It is 
difficult to form a complete impression of a multi- 
volume work on the basis of a single volume, and 
my recommendations about the usefulness of this 
volume obviously cannot be applied to volumes 1 
and 2, which I have not seen. 
The team of contributors to this volume is inter- 
national and authoritative, and on the whole they 
have done a good job. The presentation of the 
book is excellent, with an attractive type-face, 
clear layout, well-drawn figures and tables and a 
low incidence of misprints (and so it should be, 
considering the price). The average length of the 
chapters is about 30 pages including references and 
13 topics are covered. These include the role of 
folates in bacteriophages, bacteria, protozoa and 
Dictyostelium; folate nutrition in man and 
animals; folate deficiency; intestinal absorption 
and physiological disposition of folates; transport 
of folates into cells; folate- and pterin-binding pro- 
teins; excretion of folate and pterins; folates in the 
nervous system and inborn errors of pterin and 
folate metabolism. 
It is difficult to make authoritative judgments in 
areas where one is not an expert, but my impres- 
sion is that most of the articles are clearly, critical- 
ly and authoritatively written and documented. 
The book would serve as a valuable introduction to 
the nutritional and physiological aspects of folate 
metabolism if it were not so expensive. The very 
laboratories and libraries where such a comprehen- 
sive book would be of most use are likely to be 
those least able to afford to buy it. In Britain at 
least the shortage of money in University libraries 
has reached crisis proportions, and unless 
publishers waken up to this fact and its implica- 
tions (cheaper binding, more camera-ready copy), 
one of their major markets for this type of book 
will have disappeared. 
P.J. Large 
Perspectives in Receptor Classification 
Edited by J.W. Black, D.H. Jenkinson and V.P. Gerskowitch 
Alan R. Liss; New York, 1987 
xi + 295 pages. f47.00 
The sixth in a series on Receptor Biochemistry and 
Methodology, this volume is in effect the pro- 
ceedings of a conference held in 1985 to honour the 
memory of H.O. Schild. The 23 chapters were con- 
tributed by experts and the majority do directly ad- 
dress questions of receptor classification. 
The keynote contribution is by J.W. Black who 
states his concern that pharmacologists currently 
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disagree on issues as fundamental as the definition 
of a hormone and the precise nature of the hor- 
mone receptor, and are therefore unlikely to pro- 
duce a consensus on receptor classification. By 
analogy with developments in biochemistry which 
led to the establishment of the International En- 
zyme Commission’s classification of enzymes, 
Black argues that an agreed system of receptor 
classification would establish the standards against 
which proposals on any new receptor could be 
judged. The criteria, whenever they are drafted 
and accepted, will inevitably include phar- 
macological, physiological and biochemical 
evidence, a mixture that is foreshadowed by the in- 
terdisciplinary nature of the contributions to this 
volume. 
The classical pharmacology approach related 
drugs and hormones to physiological conse- 
quences. The need now, more than ever in view of 
the proliferation of receptor sub-types, is to 
describe receptor structure and the molecular 
events that follow association of ligand and recep- 
tor. The authors in this volume review in a concise 
and critical way the techniques, experimental 
evidence and theoretical concepts that are beginn- 
ing to provide the basis for a more analytical ap- 
proach to receptor classification. 
Apart from the academic interest in the subject 
that has such an impact on our understanding of 
tissue function, there are major implications for 
the drug designers who aim to produce more selec- 
tive drug action. Smith Kline & French clearly 
recognise this and are to be congratulated for sup- 
porting the conference and the publication of its 
papers. Though the volume is expensive, the 
scholarship it draws on and the manner of its 
presentation make for stimulating reading for any 
biologist with an interest in hormones and 
transmitters. 
Keith Burdett 
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Cambridge University Press; Cambridge, 1986 
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The title of this book is somewhat misleading, 
since only a small proportion of the book deals 
with receptors on tumour cells, at least in the con- 
ventional sense of this term. In the Introduction, 
the editor states “The present book is about the 
phenomenon of recognition. It attempts to 
describe the basic biology of cancer and treatment 
of the disease in terms of the tumour-specific aber- 
ration.. . and the target which this presents to an 
agent of the immune system, for a growth factor or 
to an exogenously supplied drug.” 
Of the ten chapters of the book, seven deal with 
various aspects of tumour immunology. The first 
is a good overview of natural killer cell physiology, 
with special emphasis on recognition structures, 
and activation of target cell lysis. Chapter 2 is ad- 
dressed to macrophage-mediated tumour cell 
destruction, but is concerned mainly with the use 
of liposomes for the efficient delivery of 
macrophage activation factors. Both this, and the 
next chapter, dealing with synergy between in- 
terferons, are essentially phenomenological, with 
almost no discussion of basic cellular mechanisms, 
and none at all of cellular receptors. Chapters 
7-10 deal collectively with tumour antigens, defin- 
ed exclusively by antibodies. Chapter 7 briefly 
reviews the intensive search for tumour-specific 
antigens, which has produced a number of useful 
diagnostic markers, but very few truly tumour- 
specific antigens. Chapter 8 discusses the use of fu- 
sions between tumour and normal cells to look for 
surface proteins involved in malignancy, and con- 
centrates particularly on changes in the glucose 
transport system associated with malignant 
phenotype. Chapter 9 is a brief description of a 
mouse model system for looking at potential im- 
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